Inflammatory breast cancer is typically considered a locally-advanced breast cancer and is treated aggressively with surgery, radiation therapy, chemotherapy, hormone therapy, and/or HER2 targeted therapy as appropriate.Breast cancer is found in about 1 in every 3,000 pregnant women.5,000 women will be diagnosed with this disease in 1995. It does not sound so rare does it? But compared to “normal” cases of breast cancer which will strike 182,000 women this year, it is categorized as “rare”.
The prognosis, or likely outcome, for a patient diagnosed with cancer is often viewed as the chance that the cancer will be treated successfully and that the patient will recover completely. Many factors can influence a cancer patient’s prognosis, including the type and location of the cancer, the stage of the disease, the patient’s age and overall general health, and the extent to which the patient’s disease responds to treatment.
It is important to keep in mind, however, that survival statistics are based on large numbers of patients and that an individual woman’s prognosis could be better or worse, depending on her tumor characteristics and medical history. Women who have inflammatory breast cancer are encouraged to talk with their doctor about their prognosis, given their particular situation.